These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation. Langrehr JM; Glanemann M; Guckelberger O; Klupp J; Neumann U; Machens C; Lohmann R; Knoop M; Lobeck H; Schlag H; Keck H; Settmacher U; Bechstein WO; Neuhaus PJ Clin Transplant; 1998 Aug; 12(4):303-12. PubMed ID: 9686324 [TBL] [Abstract][Full Text] [Related]
10. Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression. McAlister V; Grant D; Roy A; Yilmaz Z; Ghent C; Wall W Transplant Proc; 1993 Feb; 25(1 Pt 2):1400-1. PubMed ID: 8442154 [No Abstract] [Full Text] [Related]
11. Comparison between donor-specific transfusions with conventional immunosuppression and triple therapy including cyclosporine in living related donor kidney transplantation. Arbelaez M; Mejia G; Henao JE; Garcia A; Arango JL; Velasquez A; Restrepo J; Garcia LF Transplant Proc; 1992 Dec; 24(6):3096-7. PubMed ID: 1466072 [No Abstract] [Full Text] [Related]
12. Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection. Wiesner RH; Porayko MK; Wahlstrom HE; Gores GJ; Kamath PS; Hay JE; Krom RA Transplant Proc; 1993 Apr; 25(2):1791-3. PubMed ID: 7682352 [No Abstract] [Full Text] [Related]
13. Reduction of immunosuppressive agents after living related donor liver transplantation. Tanaka M; Otobe Y; Hashimoto T; Shimizu Y; Suzuki T; Nakamura Y; Itoh K; Satoh M; Ueda N; Manabe T Transplant Proc; 1996 Aug; 28(4):2402-3. PubMed ID: 8769268 [No Abstract] [Full Text] [Related]
14. Clinical results of quadruple drug immunosuppression in liver transplantation. Fabregat J; Fradera R; Jaurrieta E; Figueras J; Rafecas A; Rufi G; Casanovas T; Casais L; Gil Vernet S Transplant Proc; 1992 Feb; 24(1):148-9. PubMed ID: 1539217 [No Abstract] [Full Text] [Related]
15. [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases]. Cherqui D; Duvoux C; Charlotte F; Humeres R; Lauzet JY; Métreau JM; Salvat A; Rotman N; Julien M; Fagniez PL Gastroenterol Clin Biol; 1994; 18(2):115-22. PubMed ID: 8013792 [TBL] [Abstract][Full Text] [Related]
16. Quadruple-drug therapy with antithymocyte globulin in the early postoperative period after liver transplantation. Schattenfroh N; Lange D; Bechstein WO; Blumhardt G; Lohmann R; Neuhaus P Transplant Proc; 1993 Apr; 25(2):1968-9. PubMed ID: 8470245 [No Abstract] [Full Text] [Related]
17. Sri Lankan experience with three immunosuppressive protocols in living related donor kidney transplantation. Sheriffdeen AH; de Abrew K; Jayasekera G; Nanayakkara S; de Mel CP; Jayasinghe S; Fernando H; Rajakanthan K; Weerasinghe A; Kuruppruarchchi L Transplant Proc; 1992 Oct; 24(5):1818. PubMed ID: 1412862 [No Abstract] [Full Text] [Related]
18. Cyclosporine A withdrawal during follow-up after pediatric liver transplantation. Scheenstra R; Torringa ML; Waalkens HJ; Middelveld EH; Peeters PM; Slooff MJ; Gouw AS; Verkade HJ; Bijleveld CM Liver Transpl; 2006 Feb; 12(2):240-6. PubMed ID: 16447209 [TBL] [Abstract][Full Text] [Related]